EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Staphylococcus aureus |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
enzyme Cap5F is responsible for the reduction at C4 of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Pseudomonas aeruginosa |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
enzyme WbjC is responsible for the reduction at C4 of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Pseudomonas aeruginosa |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
product of enzyme WbjC. WbjC is bifunctional, catalyzing C3 epimerization of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose, the second intermediate of the pathway followed by reduction at C4 |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Staphylococcus aureus |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
reaction proceeeds via the intermediate UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Staphylococcus aureus Newman |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
enzyme Cap5F is responsible for the reduction at C4 of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Staphylococcus aureus ATCC 700699 |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
reaction proceeeds via the intermediate UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Pseudomonas aeruginosa O11 |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
product of enzyme WbjC. WbjC is bifunctional, catalyzing C3 epimerization of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose, the second intermediate of the pathway followed by reduction at C4 |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose + NADPH + H+ |
- |
Pseudomonas aeruginosa O11 |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NADP+ + H+ |
enzyme WbjC is responsible for the reduction at C4 of UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NAD(P)+ |
part of the biosynthesis of UDP-N-acetyl-L-fucosamine |
Staphylococcus aureus |
UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose + NAD(P)H + H+ |
- |
? |
1.1.1.367 | UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NAD(P)+ |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose i.e. UDP-N-acetyl-beta-L-pneumosamine |
Staphylococcus aureus |
UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose + NAD(P)H + H+ |
- |
? |